Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.
J Alzheimers Dis. 2019;70(4):1259-1274. doi: 10.3233/JAD-180678.
Alzheimer's disease (AD) pathology consists of extracellular deposits of amyloid-β peptides (Aβ) and intracellular neurofibrillary tangles. These pathological alterations are accompanied by a neuroinflammatory response consisting of increased expression of inflammatory mediators. An anti-inflammatory strategy designed to prevent or delay the development of AD would benefit from knowing when neuroinflammation appears in the transgenic models during prodromal disease stages relative to Aβ pathology. We investigated the expression patterns of inflammatory mediators in the brain of 5xFAD mice in comparison to development of Aβ deposition. Expression changes in inflammatory mediators and glial markers are more robust in female mice starting at three months of age, in contrast to males in which there is no clear trend through five months. Female and male 5xFAD mice also displayed an age-dependent increase in cortical Aβ deposition congruent with neuroinflammation. Thus, in the 5xFAD mouse model of AD, administration of an anti-inflammatory agent would be most efficacious when administered before three months of age.
阿尔茨海默病(AD)的病理学特征包括细胞外淀粉样β肽(Aβ)沉积和细胞内神经原纤维缠结。这些病理改变伴随着神经炎症反应,表现为炎症介质表达增加。旨在预防或延迟 AD 发展的抗炎策略将受益于了解神经炎症何时在 AD 前疾病阶段的转基因模型中出现,与 Aβ 病理学相比。我们研究了 5xFAD 小鼠大脑中炎症介质的表达模式与 Aβ 沉积的关系。与雄性小鼠相比,从三个月大开始,雌性小鼠的炎症介质和神经胶质标志物的表达变化更明显,而雄性小鼠则没有明显的趋势。雌性和雄性 5xFAD 小鼠的皮质 Aβ 沉积也随着年龄的增长而增加,与神经炎症一致。因此,在 AD 的 5xFAD 小鼠模型中,在三个月大之前给予抗炎药物将最有效。